BAFNA PHARMACEUTICALS LTD. - Filing Of Report Under Regulation 7(2)(B) Securities And Exchange Board Of India(Prohibition Of Insider Trading) Regulations, 2015, As Amended ('SEBI Insider Trading Regulations').
25 Dec 2023
Disclosure received under Regulation 7(2)(a) of SEBI (PIT) Regulations, 2015, from SRJR Lifesciences LLP, one of the Promoter of Bafna Pharmaceuticals Limited ("the Company") regarding disposal of equity shares of the Company.
Source:
BSE India